Per‐Ola Andersson

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

Bob Olsson, Per‐Ola Andersson, Margareta Jernås et al. · Nature Medicine · 2003 · 658 citations

Thrombopoiesis, Thrombosis, Blood Platelet +8

Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Sören Lehmann, Vladimir J.N. Bykov, Dina Ali et al. · Journal of Clinical Oncology · 2012 · 397 citations · Full text

Infections With the Tick-Borne Bacterium "Candidatus Neoehrlichia mikurensis" Mimic Noninfectious Conditions in Patients With B Cell Malignancies or Autoimmune Diseases

Anna Grankvist, Per‐Ola Andersson, Mattias Mattsson et al. · Clinical Infectious Diseases · 2014 · 104 citations · Full text

A transforming growth factor-β1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura

Per‐Ola Andersson, Dick Stockelberg, Staffan Jacobsson et al. · Annals of Hematology · 2000 · 80 citations

Inflammation, Autoimmune Disease, Immunology +7

High immunohistochemical expression of p‐AKT predicts inferior survival in patients with diffuse large B‐cell lymphoma treated with immunochemotherapy

Sverker Hasselblom, Ulrika Hansson, Markus Olsson et al. · British Journal of Haematology · 2010 · 76 citations

Hematological Malignancy, Lymphoid Neoplasia, Dlbcl Patients +14